William Patrick Burke - 01 Sep 2021 Form 3 Insider Report for NovoCure Ltd (NVCR)

Role: Chief Human Resources Officer
Signature: By: /s/ Steven Robbins, Attorney in Fact for William Patrick Burke
Issuer symbol: NVCR
Transactions as of: 01 Sep 2021
Net transactions value: $0
Form type: 3
Filing time: 03 Sep 2021, 16:34:36 UTC
Next filing: 05 Jan 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	NVCR	Ordinary Shares						10,283	01 Sep 2021	Direct
holding	NVCR	Restricted Share Units						2,657	01 Sep 2021	Direct	F1
holding	NVCR	Restricted Share Units						4,804	01 Sep 2021	Direct	F2
holding	NVCR	Restricted Share Units						1,573	01 Sep 2021	Direct	F3
holding	NVCR	Restricted Share Units						3,266	01 Sep 2021	Direct	F4
holding	NVCR	Restricted Share Units						3,634	01 Sep 2021	Direct	F5

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	17,452	$11.46	Direct	F6
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	9,750	$7.15	Direct	F6
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	7,500	$21.60	Direct	F7
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	32,103	$21.15	Direct	F8
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	10,946	$47.04	Direct	F9
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	13,896	$69.37	Direct	F10
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	4,535	$84.68	Direct	F11
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	6,001	$153.09	Direct	F12
holding	NVCR	Options to Buy Ordinary Shares							01 Sep 2021	Ordinary Shares	6,531	$137.58	Direct	F13

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted share units that are scheduled to vest on March 22, 2022, subject to the reporting person's continued employment through such date.
F2	Represents restricted share units that are scheduled to vest on March 3, 2022 and 2023, subject to the reporting person's continued employment through such dates.
F3	Represents restricted share units that are scheduled to vest on September 1, 2022 and 2023, subject to the reporting person's continued employment through such dates.
F4	Represents restricted share units that are scheduled to vest on March 2, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
F5	Represents restricted share units that are scheduled to vest on September 1, 2022, 2023 and 2024, subject to the reporting person's continued employment through such dates.
F6	Fully vested as of the date hereof.
F7	These options vest on October 31, 2021, subject to the reporting person's continued employment through such date.
F8	Options to buy 32,103 ordinary shares, 24,078 shares of which are currently exercisable and the remaining 8,025 vest and become exercisable on February 27, 2022, subject to the reporting person's continued employment through such date.
F9	Options to buy 10,946 ordinary shares, 3,649 shares of which are currently exercisable and the remaining 7,297 shares of which will vest and become exercisable in equal installments on each of March 22, 2022 March 22, 2023, subject to the reporting person's continued employment through such dates.
F10	Options to buy 13,896 ordinary shares, 3,474 shares of which are currently exercisable and the remaining 10,422 shares will vest and become exercisable in equal installments on each of March 3, 2022, March 3, 2023 and March 3, 2024, subject to the reporting person's continued employment through such dates.
F11	Options to buy 4,535 ordinary shares, 1,134 shares of which are currently exercisable and the remaining 3,401 shares will vest and become exercisable in equal installments on each of September 1, 2022, September 1, 2023 and September 1, 2024, subject to the reporting person's continued employment through such dates.
F12	One-quarter of these options is scheduled to vest on each of March 2, 2022, March 2, 2023, March 2, 2024 and March 2, 2025, subject to the reporting person's continued employment through such dates.
F13	One-quarter of these options is scheduled to vest on each of September 1, 2022, September 1, 2023, September 1, 2024 and September 1, 2025, subject to the reporting person's continued employment through such dates.